Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514966
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514966
Short-Acting Insulin Market, By Drug, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
PUBLISHED:
PAGES: 288 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Short-Acting Insulin Market size was valued at USD 7,524.2 Million in 2023, expanding at a CAGR of 4.50% from 2024 to 2032.
The Short-Acting Insulin Market refers to the market segment dealing in insulin medications of a quick onset of action with a short, lengthier duration of effect. Short-acting insulin aims to provide glycemia control immediately post-meal to avoid glucose spikes due to food intake. Short-acting insulin is usually administered before or immediately after meals in order to closely mimic the body's natural supply of insulin to food intake. This is the very market of different pharmaceutical companies producing and distributing such medications to people with diabetes, so that these people may use them in a way of helping their body system regulate its blood sugar level effectively.
Short-Acting Insulin Market- Market Dynamics
Government's Initiatives to Prevent the Spread of Diabetes Drive Market Growth
Government policies at the federal, state, and municipal levels are critical to improving the quality and safety of healthcare. Changes in policy, systems, and the environment (PSE) are critical components of a long-term strategy to prevent chronic diseases. The goal of legislative regulations and environmental alterations is to make healthy behaviours more available or desirable while making detrimental exposures more difficult or illegal. Systemic interventions strive to improve an agency's or organization's operations and service delivery to the community. Diabetes is a chronic condition affecting over 30 million individuals. The Affordable Care Act of 2010 (ACA) established a shared responsibility paradigm among the government, employers, and individuals to ensure that everyone has unlimited access to affordable, high-quality health insurance in their local regions.
Short-Acting Insulin Market- Key Insights
Our research analyst estimates that the global market will develop at a CAGR of approximately 4.50% from 2024 to 2032.
Based on Drug segmentation, the Novolog drugs segment will dominate the worldwide insulin market in 2023.
On the basis of region, North America was the leading revenue generator in 2023
Short-Acting Insulin Market- Segmentation Analysis:
The Global Short-Acting Insulin Market is segmented on the basis of Drug and Region.
The market is divided into three categories based on drugs: Novolog, Humalog, and Humulin. The Novolog drugs segment will dominate the worldwide insulin market in 2023, with the greatest CAGR projected. Novolog is a rapid-acting insulin that works in tandem with mealtime insulin. It was developed largely to attain pharmacokinetic as well as pharmacodynamic features that are more closely related to the physiological mealtime response of insulin in a person without diabetes.
Short-Acting Insulin Market- Geographical Insights
Geographically, this market is present in North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These zones are further split based on which countries bring business. North America dominates the market. North America, the world's most developed and largest economy, has world-class healthcare facilities, which is the major basis for its market dominance.
The Asia-Pacific market is predicted to experience the quickest revenue growth rate in the worldwide Short-Acting Insulin market during the forecast period; the Asia-Pacific region's success can be attributed to the amazing expansion of the region's healthcare industry, which has grown at a rapid pace.
Short-Acting Insulin Market- Competitive Landscape:
In the competitive Short-Acting Insulin Market, several important pharmaceutical companies are actively involved in the development and marketing of rapid-acting insulin products. These businesses compete based on product efficacy, safety, cost, and market presence. Some significant participants in the short-acting insulin industry are Sanofi, Eli Lilly & Company, Novo Nordisk AS, Verily, and Sensile.
Recent Developments:
In June 2021, Eli Lilly and Company announced a $400 million investment to expand its production capacity.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as following:
GLOBAL SHORT-ACTING INSULIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Novo Nordisk AS
Sanofi
Eli Lilly and Company
Verily
Sensile
Others
GLOBAL SHORT-ACTING INSULIN MARKET, BY DRUG- MARKET ANALYSIS, 2019 - 2032
- Novolog
- Humalog
- Humulin
GLOBAL SHORT-ACTING INSULIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV3095
Table of Contents
1. Short-Acting Insulin Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Short-Acting Insulin Market Snippet by Drug
- 2.1.2. Short-Acting Insulin Market Snippet by Country
- 2.1.3. Short-Acting Insulin Market Snippet by Region
- 2.2. Competitive Insights
3. Short-Acting Insulin Key Market Trends
- 3.1. Short-Acting Insulin Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Short-Acting Insulin Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Short-Acting Insulin Market Opportunities
- 3.4. Short-Acting Insulin Market Future Trends
4. Short-Acting Insulin Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Short-Acting Insulin Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Short-Acting Insulin Market Landscape
- 6.1. Short-Acting Insulin Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Short-Acting Insulin Market - By Drug
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Drug, 2023 & 2032 (%)
- 7.1.2. Novolog
- 7.1.3. Humalog
- 7.1.4. Humulin
8. Short-Acting Insulin Market- By Geography
- 8.1. Introduction
- 8.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 8.2. North America
- 8.2.1. Overview
- 8.2.2. Short-Acting Insulin Key Manufacturers in North America
- 8.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.2.4. North America Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.2.5. U.S.
- 8.2.5.1. Overview
- 8.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.2.5.3. U.S. Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.2.6. Canada
- 8.2.6.1. Overview
- 8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.2.6.3. Canada Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3. Europe
- 8.3.1. Overview
- 8.3.2. Short-Acting Insulin Key Manufacturers in Europe
- 8.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.3.4. Europe Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.5. Germany
- 8.3.5.1. Overview
- 8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.3.5.3. Germany Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.6. Italy
- 8.3.6.1. Overview
- 8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.3.6.3. Italy Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.7. United Kingdom
- 8.3.7.1. Overview
- 8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.3.7.3. United Kingdom Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.8. France
- 8.3.8.1. Overview
- 8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.3.8.3. France Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.9. Russia
- 8.3.9.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.3.9.2. Russia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.10. Netherlands
- 8.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.3.10.2. Netherlands Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.11. Sweden
- 8.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.3.11.2. Sweden Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.12. Poland
- 8.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.3.12.2. Poland Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.13. Rest of Europe
- 8.3.13.1. Overview
- 8.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.3.13.3. Rest of the Europe Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4. Asia Pacific (APAC)
- 8.4.1. Overview
- 8.4.2. Short-Acting Insulin Key Manufacturers in Asia Pacific
- 8.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.4.4. Asia Pacific Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.5. India
- 8.4.5.1. Overview
- 8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.4.5.3. India Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.6. China
- 8.4.6.1. Overview
- 8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.4.6.3. China Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.7. Japan
- 8.4.7.1. Overview
- 8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.4.7.3. Japan Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.8. South Korea
- 8.4.8.1. Overview
- 8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.4.8.3. South Korea Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.9. Australia
- 8.4.9.1. Overview
- 8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.4.9.3. Australia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.10. Thailand
- 8.4.10.1. Overview
- 8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.4.10.3. Thailand Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.11. Indonesia
- 8.4.11.1. Overview
- 8.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.4.11.3. Indonesia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.12. Philippines
- 8.4.12.1. Overview
- 8.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.4.12.3. Philippines Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.13. Rest of APAC
- 8.4.13.1. Overview
- 8.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.4.13.3. Rest of APAC Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.5. Latin America
- 8.5.1. Overview
- 8.5.2. Short-Acting Insulin Key Manufacturers in Latin America
- 8.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.5.4. Latin America Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.5.5. Brazil
- 8.5.5.1. Overview
- 8.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.5.5.3. Brazil Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.5.6. Mexico
- 8.5.6.1. Overview
- 8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.5.6.3. Mexico Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.5.7. Argentina
- 8.5.7.1. Overview
- 8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.5.7.3. Argentina Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.5.8. Colombia
- 8.5.8.1. Overview
- 8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.5.8.3. Colombia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.5.9. Rest of LATAM
- 8.5.9.1. Overview
- 8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.5.9.3. Rest of LATAM Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.6. Middle East and Africa
- 8.6.1. Overview
- 8.6.2. Short-Acting Insulin Key Manufacturers in Middle East and Africa
- 8.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.6.4. Middle East and Africa Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.6.5. Saudi Arabia
- 8.6.5.1. Overview
- 8.6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.6.5.3. Saudi Arabia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.6.6. United Arab Emirates
- 8.6.6.1. Overview
- 8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.6.6.3. United Arab Emirates Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.6.7. Israel
- 8.6.7.1. Overview
- 8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.6.7.3. Israel Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.6.8. Turkey
- 8.6.8.1. Overview
- 8.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.6.8.3. Turkey Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.6.9. Algeria
- 8.6.9.1. Overview
- 8.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.6.9.3. Algeria Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.6.10. Egypt
- 8.6.10.1. Overview
- 8.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.6.10.3. Egypt Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.6.11. Rest of MEA
- 8.6.11.1. Overview
- 8.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 8.6.11.3. Rest of MEA Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
9. Key Vendor Analysis- Short-Acting Insulin Industry
- 9.1. Competitive Dashboard
- 9.2. Company Profiles
- 9.2.1. Novo Nordisk AS
- 9.2.2. Sanofi
- 9.2.3. Eli Lilly and Company
- 9.2.4. Verily
- 9.2.5. Sensile
- 9.2.6. Others
10. 360 Degree Analyst View
11. Appendix
- 11.1. Research Methodology
- 11.2. References
- 11.3. Abbreviations
- 11.4. Disclaimer
- 11.5. Contact Us
Product Code: ANV3095
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Short-Acting Insulin Market: Drug Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Drug
- TABLE Global Short-Acting Insulin Market, by Drug 2019-2032 (USD Million)
- TABLE TABLE TABLE Short-Acting Insulin Market: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Short-Acting Insulin Market, by Region 2019-2032 (USD Million)
- TABLE North America Short-Acting Insulin Market, by Country, 2019-2032 (UD Million)
- TABLE North America Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
- TABLE Europe Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
- TABLE Europe Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
- TABLE Asia Pacific Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
- TABLE Latin America Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
- TABLE Latin America Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
- TABLE Middle East and Africa Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
T
List of Figures
- FIGURE Short-Acting Insulin Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2023
- FIGURE Drug segment market share analysis, 2023 & 2032
- FIGURE Drug segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE FIGURE Regional segment market share analysis, 2023 & 2032
- FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE North America Short-Acting Insulin Market share and leading players, 2023
- FIGURE Europe Short-Acting Insulin Market share and leading players, 2023
- FIGURE Asia Pacific Short-Acting Insulin Market share and leading players, 2023
- FIGURE Latin America Short-Acting Insulin Market share and leading players, 2023
- FIGURE Middle East and Africa Short-Acting Insulin Market share and leading players, 2023
- FIGURE North America market share analysis by country, 2023
- FIGURE U.S. Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Canada Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Europe Short-Acting Insulin Market share analysis by country, 2023
- FIGURE Germany Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Spain Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Italy Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE France Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE UK Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Russia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Netherlands Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Sweden Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Poland Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of the Europe Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Asia Pacific Short-Acting Insulin Market share analysis by country, 2023
- FIGURE India Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE China Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Japan Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE South Korea Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Australia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Thailand Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Indonesia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Philippines Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of APAC Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America Short-Acting Insulin Market share analysis by country, 2023
- FIGURE Brazil Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Mexico Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Argentina Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Colombia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of LATAM Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa Short-Acting Insulin Market share analysis by country, 2023
- FIGURE Saudi Arabia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE United Arab Emirates Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Israel Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Turkey Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Algeria Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Egypt Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of MEA Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.